Literature DB >> 4396960

Action of thymoxamine on mydriasis induced by levodopa and dopamine.

A S Spiers, D B Calne, S D Vakil, T M French.   

Abstract

Eye-drops of levodopa and dopamine induce pupillary dilatation which is inhibited by thymoxamine, an alpha-adrenergic blocking drug. This indicates that the mydriatic action of levodopa and dopamine involves excitation of alpha-adrenergic receptors of the dilator pupillae muscle. Such a conclusion is in accord with the previously expressed suggestion that levodopa is rapidly converted to dopamine, which displaces noradrenaline from adrenergic nerve endings.The findings that dopamine exerts alpha-adrenergic effects at the periphery may be construed as evidence in support of the view that the hypotensive action of levodopa is mediated via the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4396960      PMCID: PMC1796205          DOI: 10.1136/bmj.2.5759.438

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  DIRECT RENAL VASODILATATION PRODUCED BY DOPAMINE IN THE DOG.

Authors:  J L MCNAY; R H MCDONALD; L I GOLDBERG
Journal:  Circ Res       Date:  1965-06       Impact factor: 17.367

2.  Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.

Authors:  G Bartholini; W P Burkard; A Pletscher
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

3.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

4.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

5.  Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.

Authors:  M I Weintraub; D Gaasterland; M H Van Woert
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

6.  Miosis during L-dopa therapy.

Authors:  A S Spiers; D B Calne; P M Fayers
Journal:  Br Med J       Date:  1970-06-13

7.  Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.

Authors:  A M Watanabe; T N Chase; P V Cardon
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

8.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

9.  Action of dopamine on the human iris.

Authors:  A S Spiers; D B Calne
Journal:  Br Med J       Date:  1969-11-08

10.  Hypotension caused by L-dopa.

Authors:  D B Calne; J Brennan; A S Spiers; G M Stern
Journal:  Br Med J       Date:  1970-02-21
  10 in total
  4 in total

1.  Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.

Authors:  O Bartošová; C Bonnet; O Ulmanová; M Šíma; F Perlík; E Růžička; O Slanař
Journal:  J Neural Transm (Vienna)       Date:  2017-12-19       Impact factor: 3.575

2.  Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%.

Authors:  F Drago; A Dal Bello; V Marino; R Pisati; E Lodola; P Barbieri
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  The effect of L-dopa on pupillary diameter in mice.

Authors:  A D Korczyn; O Keren
Journal:  Experientia       Date:  1982-04-15

4.  Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.

Authors:  J Sharpe; A Marquez-Julio; P Ashby
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.